Cargando…
Structural basis of translation inhibition by cadazolid, a novel quinoxolidinone antibiotic
Oxazolidinones are synthetic antibiotics used for treatment of infections caused by Gram-positive bacteria. They target the bacterial protein synthesis machinery by binding to the peptidyl transferase centre (PTC) of the ribosome and interfering with the peptidyl transferase reaction. Cadazolid is t...
Autores principales: | Scaiola, Alain, Leibundgut, Marc, Boehringer, Daniel, Caspers, Patrick, Bur, Daniel, Locher, Hans H., Rueedi, Georg, Ritz, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449356/ https://www.ncbi.nlm.nih.gov/pubmed/30948752 http://dx.doi.org/10.1038/s41598-019-42155-4 |
Ejemplares similares
-
Structures of the E. coli translating ribosome with SRP and its receptor and with the translocon
por: Jomaa, Ahmad, et al.
Publicado: (2016) -
Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection
por: Gerding, D. N., et al.
Publicado: (2016) -
The complete structure of the chloroplast 70S ribosome in complex with translation factor pY
por: Bieri, Philipp, et al.
Publicado: (2016) -
Cadazolid vs Vancomycin for the Treatment of Clostridioides difficile Infection: Systematic Review with Meta-analysis
por: Muhammad, Aziz, et al.
Publicado: (2020) -
Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome
por: Bhatt, Pramod R., et al.
Publicado: (2021)